Stem Cell Stocks Jump on New Congressional Promise

Stem cell stocks gained big time on Thursday as the new U.S. congress was set to take helm. The new Democratic agenda promises to ease restrictions on embryonic stem cell research funding imposed by the Bush administration.

While Bush is expected to veto the new legislation, critics believe there is enough push in the Senate to override the veto. It is expected that under a Democratic environment biotech stocks in general should perform well over the next few years, especially in controversial areas such as embryonic stem cell research.

Shares of Geron (GERN), StemCells (STEM), Aastrom Biosciences (ASTM), Thermogenesis (KOOL), LifeCell (LIFC), Advanced Cell Technology (ACTC), ViaCell (VIAC), Cryo-Cell (CCEL.OB), and Cord Blood America [CBAI.OB] all gained on the day.

Aastrom, StemCells, Cord Blood America and Advanced Cell Technology all gained by double digit percentage points.

Comments

[borisb:]

yeah, the Stem Cells Inc- stem has bounced 36% in 6 trading days.
and the Lifecell-LIFC has the cryogenic angle to be the base structure-fabric of dozens
of next generation stem cell products... as stated by the
Austrailian Stem Cell Research Institute.

2007 Jan 06 09:27 AM

[borisb:]

all the complex new stem cell products are going to need a cryogenic component,
but there is only one large scale company in world working on it since 1985 and
holds all the patents... Lifecell. per German PDF file from 2004, that states no
tissue engineeing firm has a sales block greater then $10 million except for Lifecell,
which is on course to do about $130+ million in 2006.

2007 Jan 06 09:33 AM

[patp:]

check out ACTC regenerative medicine

Jan 19 04:40 PM